FDA
approval
· 2022-03-14
FDA Approved: METHYLPHENIDATE — Original Application (Mylan Pharmaceuticals Inc.)
Summary
FDA approved a generic methylphenidate product (Original Application) from Mylan Pharmaceuticals Inc., for conditions such as ADHD and narcolepsy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for METHYLPHENIDATE (METHYLPHENIDATE)